Paul Bensadoun

Paul Bensadoun

Auto-generated profile, based on publicly available information

Paul Bensadoun

INSERM IRMB UMR1183, Hôpital Saint Eloi, Université de Montpellier, Montpellier, France

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JBJennifer Beauvarlet
Jennifer Beauvarlet
PBPaul Bensadoun
Paul Bensadoun
EDElodie Darbo
Elodie Darbo
GLGaelle Labrunie
Gaelle Labrunie
BRBenoît Rousseau
Benoît Rousseau
MMMojgan Djavahery Mergny
Mojgan Djavahery Mergny
G-quadruplex ligands exert their antiproliferative effects through telomere-dependent and telomere-independent mechanisms, but the inter-relationships among autophagy, cell growth arrest and cell death induced by these ligands remain largely unexplored. Here, we demonstrate that the G-quadruplex ligand 20A causes growth arrest of cancer cells in culture and in a HeLa cell xenografted mouse model. This response is associated with the induction of senescence and apoptosis. Transcriptomic analysis of 20A treated cells reveals a significant functional enrichment of biological pathways related to growth arrest, DNA damage response and the lysosomal pathway. 20A elicits global DNA damage but not telomeric damage and activates the ATM and autophagy pathways. Loss of ATM following 20A treatment inhibits both autophagy and senescence and sensitizes cells to death. Moreover, disruption of autophagy by deletion of two essential autophagy genes ATG5 and ATG7 leads to failure of CHK1 activation by 20A and subsequently increased cell death. Our results, therefore, identify the activation of ATM by 20A as a critical player in the balance between senescence and apoptosis and autophagy as one of the key mediators of such regulation. Thus, targeting the ATM/autophagy pathway might be a promising strategy to achieve the maximal anticancer effect of this compound.

18 July 2014 in Cell Death & Differentiation
Verified
Journal Article
Closed access
ATA Trocoli
A Trocoli
PBP Bensadoun
P Bensadoun
RERICHARD Elodie
RICHARD Elodie
GLG Labrunie
G Labrunie
FMF Merhi
F Merhi
MMMojgan Djavahery Mergny
Mojgan Djavahery Mergny

1 September 2013 in Hepatology
Verified
Journal Article
Closed access
PDF file
CRChristophe Rodriguez
Christophe Rodriguez
SCStéphane Chevaliez
Stéphane Chevaliez
PBPaul Bensadoun
Paul Bensadoun
JPJean-Michel Pawlotsky
Jean-Michel Pawlotsky

15 July 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PBPatrick Bogdanowicz
Patrick Bogdanowicz
PBPaul Bensadoun
Paul Bensadoun
MNMaïté Noizet
Maïté Noizet
BBBenoît Béganton
Benoît Béganton
APArmony Philippe
Armony Philippe
HDHélène Duplan
Hélène Duplan
Intrinsic and extrinsic factors, including lifestyle and sun exposure, can contribute to cell senescence, which impairs skin homeostasis, that may in turn lead to skin aging. Senescent cells have a specific secretome, called the senescence-associated secretory phenotype (SASP) that includes MMPs, CXCLs and S100A8/9. Reducing the SASP with senotherapeutics is a promising strategy to reduce skin aging. Here we evaluated the effect of a formula containing niacinamide and hyaluronic acid, which are known to limit senescence and skin aging. We conducted three different studies. (1) Ex vivo explants treated with the formula had more collagen and glycosaminoglycan. (2) In a clinical trial with forty-four women, two months of treatment improved fine lines, wrinkles, luminosity, smoothness, homogeneity, and plumpness. (3) In a third study on thirty women, we treated one arm for two months and took skin biopsies to study gene expression. 101 mRNAs and 13 miRNAs were differentially expressed. We observed a likely senomorphic effect, as there was a decrease in many SASP genes including MMP12 and CXCL9 and a significant downregulation of autocrine signaling genes: S100A8 and S100A9. These pharmaco-clinical results are the first to demonstrate the senomorphic properties of an effective anti-aging formula in skin.

1 May 2016 in Cell Reports
Verified
Journal Article
Open access
MOMüge Ogrunc
Müge Ogrunc
RMRicardo Ivan Martinez-Zamudio
Ricardo Ivan Martinez-Zamudio
PSPaul Ben Sadoun
Paul Ben Sadoun
GDGregory Dore
Gregory Dore
HSHelene Schwerer
Helene Schwerer
OBOliver Bischof
Oliver Bischof
Oncogene-induced senescence (OIS) is a potent barrier for the transformation of pre-cancerous cells. The molecular pathways involved in the execution of OIS are still incompletely understood, but they include chronic DNA damage signaling and post-translational modifications of key factors. Here, we show that OIS-associated transcriptional downregulation of deubiquitinating enzyme USP1 triggers and maintains a DNA damage checkpoint response with atypical DNA lesions that is dependent on functional FANCD2-FI-ATR-CHK1-p53-CDKN1A signaling. We find that a reduced USP1 level causes aberrant aggregation of its target FANCD2 concomitant with replication stress, accumulation, and colocalization of γ-H2Ax and p53-binding protein 1 (53BP1) in large and unusual sparse DNA damage foci and an increased number of polyploid cells and cells arrested in G2/M, as well as a sensitization of senescence-bypassing cells to DNA interstrand crosslinking-mediated cell death. Our study identifies USP1 as a key senescence regulator controlling genomic integrity and a promising target for anti-cancer therapy.

3 July 2018 in Cell Cycle
Verified
Journal Article
Closed access
JRJuan Carlos Rivera-Mulia
Juan Carlos Rivera-Mulia
HSHélène Schwerer
Hélène Schwerer
EBEmilie Besnard
Emilie Besnard
RDRomain Desprat
Romain Desprat
CTClaudia Trevilla-Garcia
Claudia Trevilla-Garcia
Jean-marc LemaitreJean-marc Lemaitre
Jean-marc Lemaitre
Organismal aging entails a gradual decline of normal physiological functions and a major contributor to this decline is withdrawal of the cell cycle, known as senescence. Senescence can result from telomere diminution leading to a finite number of population doublings, known as replicative senescence (RS), or from oncogene overexpression, as a protective mechanism against cancer. Senescence is associated with large-scale chromatin re-organization and changes in gene expression. Replication stress is a complex phenomenon, defined as the slowing or stalling of replication fork progression and/or DNA synthesis, which has serious implications for genome stability, and consequently in human diseases. Aberrant replication fork structures activate the replication stress response leading to the activation of dormant origins, which is thought to be a safeguard mechanism to complete DNA replication on time. However, the relationship between replicative stress and the changes in the spatiotemporal program of DNA replication in senescence progression remains unclear. Here, we studied the DNA replication program during senescence progression in proliferative and pre-senescent cells from donors of various ages by single DNA fiber combing of replicated DNA, origin mapping by sequencing short nascent strands and genome-wide profiling of replication timing (TRT). We demonstrate that, progression into RS leads to reduced replication fork rates and activation of dormant origins, which are the hallmarks of replication stress. However, with the exception of a delay in RT of the CREB5 gene in all pre-senescent cells, RT was globally unaffected by replication stress during entry into either oncogene-induced or RS. Consequently, we conclude that RT alterations associated with physiological and accelerated aging, do not result from senescence progression. Our results clarify the interplay between senescence, aging and replication programs and demonstrate that RT is largely resistant to replication stress.